Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus

Objective To evaluate the effects of targeting Ikaros and Aiolos by cereblon modulator iberdomide on the activation and differentiation of B-cells from patients with systemic lupus erythematosus (SLE).Methods CD19+ B-cells isolated from the peripheral blood of patients with SLE (n=41) were cultured...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Costantino Pitzalis, Michele Bombardieri, Patrick Gordon, Daniele Mauro, Felice Rivellese, Debasish Pyne, Myles J Lewis, Katriona Goldmann, Sotiria Manou-Stathopoulou, Ravindra Rajakariar, Peter Schafer
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMJ Publishing Group 2021-05-01
Saila:	Lupus Science and Medicine
Sarrera elektronikoa:	https://lupus.bmj.com/content/8/1/e000445.full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!